Skip to main content
JOHNSON & JOHNSON logo

JOHNSON & JOHNSON — Investor Relations & Filings

Ticker · JNJ ISIN · US4781601046 LEI · 549300G0CFPGEF6X2043 US Manufacturing
Open in API
Filings indexed 3,142 across all filing types
Latest filing 2014-12-12 Director's Dealing
Country US United States of America
Listing US JNJ

About JOHNSON & JOHNSON

https://www.jnj.com/

Johnson & Johnson is a healthcare company that operates through two primary segments: Innovative Medicine and MedTech. The Innovative Medicine division is focused on the research, development, and delivery of new treatments for complex diseases in areas such as oncology, immunology, neuroscience, and cardiopulmonary conditions. The MedTech segment develops and provides a broad portfolio of medical technologies and solutions. It innovates in fields including surgery, orthopaedics, vision, and interventional solutions, aiming to create smarter, less invasive, and more personalized healthcare treatments. The company's mission is to address significant health challenges through science-based innovation at the intersection of biology and technology.

Recent filings

Filing Released Lang Actions
Director's Dealing 2014
Director's Dealing
2014-12-12 English
Director's Dealing 2014
Director's Dealing
2014-12-12 English
Director's Dealing 2014
Director's Dealing
2014-12-12 English
8-K
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated November 18, 2014, reporting the issuance and sale of various notes (debt securities) by Johnson & Johnson. It details underwriting agreements and the terms of the notes issued, including principal amounts, interest rates, and maturity dates. The document includes legal opinions and consents related to the issuance. There are no financial statements or comprehensive financial data presented, nor is this a full annual or quarterly report. The content focuses on the company's financing activities, specifically the issuance of debt securities. Therefore, this document fits the category of Capital/Financing Update (CAP). The document length is 4274 characters, which is consistent with a detailed announcement rather than a brief notice or a full report.
2014-11-21 English
FINAL PROSPECTUS SUPPLEMENT
Capital/Financing Update Classification · 100% confidence The document is a 'Final Prospectus Supplement' filed pursuant to Rule 424(b)(5) under the Securities Act of 1933. It details the offering of various notes (debt securities) by Johnson & Johnson, including amounts, interest rates, maturity dates, underwriting discounts, and use of proceeds. The document includes detailed terms of the offering, risk factors, and legal matters related to the issuance of debt securities. This type of document is a capital raising disclosure related to debt issuance and financing activities. It is not an annual report, earnings release, or any other type of financial report. It is a detailed financing update and offering document for investors. Therefore, the appropriate classification is 'Capital/Financing Update' (CAP).
2014-11-20 English
FREE WRITING PROSPECTUS
Capital/Financing Update Classification · 95% confidence The document is titled 'Free Writing Prospectus' and is filed pursuant to Rule 433, which relates to securities offerings. It contains detailed information about a debt issuance, specifically 4.375% Senior Unsecured Notes due 2033 by Johnson & Johnson, including terms such as coupon rate, maturity date, pricing, underwriting details, and ratings. This is a pricing term sheet for a debt offering, which is a capital raising activity. The document is not a full financial report, earnings release, or regulatory filing but an update on financing terms. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is 2747 characters, which is consistent with a term sheet or offering document rather than a full report.
2014-11-19 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.